Literature DB >> 16452549

Association between serum ferritin and the insulin resistance syndrome in a representative population.

C E Wrede1, R Buettner, L C Bollheimer, J Schölmerich, K-D Palitzsch, C Hellerbrand.   

Abstract

OBJECTIVE: Unexplained hepatic iron overload with increased serum ferritin (SF) values has been associated with the insulin resistance syndrome (IRS), defined by the presence of one or more of the following criteria: increased body mass index (BMI), diabetes, hyperlipidemia or hypertension. However, as yet the association between IRS and SF in a representative population has not been investigated.
METHODS: The study subjects participated in a nationwide epidemiological survey on metabolic disorders in the adult German population. The 1200 probands included in this study are representative of the German population. To eliminate major causes of secondary iron overload, 114 (9.5%) subjects with excessive alcohol consumption and 16 (1.5%) subjects with serological evidence for hepatitis B or C were excluded. For all remaining 1070 probands, complete clinical data of SF, HbA1c, known diabetes, BMI, cholesterol, high-density lipoprotein-cholesterol and blood pressure were available.
RESULTS: SF values were significantly increased in men and women with high BMI (> 25 kg/m2), increased cholesterol (> 200 mg/dl), and increased systolic (> 160 mmHg) blood pressure, in women with diabetes, and in men with increased diastolic (> 95 mmHg) blood pressure. Furthermore, there was a significant correlation between the number of IRS criteria and SF.
CONCLUSIONS: This study shows a significant correlation between SF and the presence of IRS criteria in a large representative population. Interestingly, the severity of the IRS seems to be associated with increased SF levels suggesting a causal connection. Further studies are required to investigate the pathophysiological mechanism and consequences of increased SF levels in patients with IRS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16452549     DOI: 10.1530/eje.1.02083

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  35 in total

1.  Iron deposits and dietary patterns in familial combined hyperlipidemia and familial hypertriglyceridemia.

Authors:  Rocio Mateo-Gallego; Maria Solanas-Barca; Elena Burillo; Ana Cenarro; Iva Marques-Lopes; Fernando Civeira
Journal:  J Physiol Biochem       Date:  2010-07-20       Impact factor: 4.158

Review 2.  Dysregulation of iron and copper homeostasis in nonalcoholic fatty liver.

Authors:  Elmar Aigner; Günter Weiss; Christian Datz
Journal:  World J Hepatol       Date:  2015-02-27

3.  Hypoxia-inducible factor-1alpha regulates beta cell function in mouse and human islets.

Authors:  Kim Cheng; Kenneth Ho; Rebecca Stokes; Christopher Scott; Sue Mei Lau; Wayne J Hawthorne; Philip J O'Connell; Thomas Loudovaris; Thomas W Kay; Rohit N Kulkarni; Terumasa Okada; Xiaohui L Wang; Sun Hee Yim; Yatrik Shah; Shane T Grey; Andrew V Biankin; James G Kench; D Ross Laybutt; Frank J Gonzalez; C Ronald Kahn; Jenny E Gunton
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

Review 4.  Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease.

Authors:  Luca Valenti; Paola Dongiovanni; Silvia Fargion
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

5.  Hyperferritinemia in the Chinese and Asian community: a retrospective review of the University of British Columbia experience.

Authors:  Paul R Yenson; Eric M Yoshida; Charles H Li; Henry V Chung; Peter Wk Tsang
Journal:  Can J Gastroenterol       Date:  2008-01       Impact factor: 3.522

6.  Angiotensin II alters the expression of duodenal iron transporters, hepatic hepcidin, and body iron distribution in mice.

Authors:  Soichiro Tajima; Yasumasa Ikeda; Hideaki Enomoto; Mizuki Imao; Yuya Horinouchi; Yuki Izawa-Ishizawa; Yoshitaka Kihira; Licht Miyamoto; Keisuke Ishizawa; Koichiro Tsuchiya; Toshiaki Tamaki
Journal:  Eur J Nutr       Date:  2014-08-07       Impact factor: 5.614

7.  Ferroportin Q248h, dietary iron, and serum ferritin in community African-Americans with low to high alcohol consumption.

Authors:  Victor R Gordeuk; Sharmin F Diaz; Gladys O Onojobi; Ishmael Kasvosve; Zufan Debebe; Amanuel Edossa; Jeremy M Pantin; Shigang Xiong; Sergei Nekhai; Mehdi Nouraie; Hidekazu Tsukamoto; Robert E Taylor
Journal:  Alcohol Clin Exp Res       Date:  2008-09-06       Impact factor: 3.455

8.  Screening for hemochromatosis by measuring ferritin levels: a more effective approach.

Authors:  Jill Waalen; Vincent J Felitti; Terri Gelbart; Ernest Beutler
Journal:  Blood       Date:  2007-11-19       Impact factor: 22.113

9.  Characteristics of participants with self-reported hemochromatosis or iron overload at HEIRS study initial screening.

Authors:  James C Barton; Ronald T Acton; Catherine Leiendecker-Foster; Laura Lovato; Paul C Adams; John H Eckfeldt; Christine E McLaren; Jacob A Reiss; Gordon D McLaren; David M Reboussin; Victor R Gordeuk; Mark R Speechley; Richard D Press; Fitzroy W Dawkins
Journal:  Am J Hematol       Date:  2008-02       Impact factor: 10.047

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.